Cargando…

NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells

BACKGROUND: In therapeutic cancer vaccination, monocyte-derived dendritic cells (moDCs) efficiently activate specific T-cell responses; however, optimizing the activation of innate immune cells could support and improve the antitumor effects. A major disadvantage of moDCs matured with the standard c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosch, Naomi C., Voll, Reinhard E., Voskens, Caroline J., Gross, Stefanie, Seliger, Barbara, Schuler, Gerold, Schaft, Niels, Dörrie, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909276/ https://www.ncbi.nlm.nih.gov/pubmed/31853267 http://dx.doi.org/10.1177/1758835919891622

Ejemplares similares

A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells †
por: Bosch, Naomi C., et al.
Publicado: (2021)

Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination
por: Gerer, Kerstin F., et al.
Publicado: (2017)

Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
por: Dörrie, Jan, et al.
Publicado: (2020)

BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
por: Hoyer, Stefanie, et al.
Publicado: (2021)

Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells
por: Hoyer, Stefanie, et al.
Publicado: (2015)

CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia
por: Harrer, Dennis C., et al.
Publicado: (2019)

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
por: Dörrie, Jan, et al.
Publicado: (2018)

A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma
por: Koch, Elias A. T., et al.
Publicado: (2022)

Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance
por: Wiesinger, Manuel, et al.
Publicado: (2019)

Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC
por: Schierer, Stefan, et al.
Publicado: (2018)

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma
por: Harrer, Dennis C., et al.
Publicado: (2017)

Just One Position-Independent Lysine Residue Can Direct MelanA into Proteasomal Degradation following N-Terminal Fusion of Ubiquitin
por: Setz, Christian, et al.
Publicado: (2013)

GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family
por: Lutz, Manfred B., et al.
Publicado: (2017)

Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization
por: Lai, Xin, et al.
Publicado: (2022)

The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency
por: Bigley, Venetia, et al.
Publicado: (2011)

CARs: Beyond T Cells and T Cell-Derived Signaling Domains
por: Sievers, Nico M., et al.
Publicado: (2020)

Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation
por: Knippertz, Ilka, et al.
Publicado: (2016)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

The future of affordable cancer immunotherapy
por: Schaft, Niels, et al.
Publicado: (2023)

T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options
por: Gehrcken, Laura, et al.
Publicado: (2021)

CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities–Merits and Challenges
por: Harrer, Dennis C., et al.
Publicado: (2019)

Human Adenovirus-Specific γ/δ and CD8(+) T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation
por: Dörrie, Jan, et al.
Publicado: (2014)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
por: Seliger, Barbara, et al.
Publicado: (2022)

β-Glucan-Induced IL-10 Secretion by Monocytes Triggers Porcine NK Cell Cytotoxicity
por: Hermans, Leen, et al.
Publicado: (2021)

Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells
por: Schuler-Thurner, Beatrice, et al.
Publicado: (2002)

Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy
por: Lai, Xin, et al.
Publicado: (2021)

Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases
por: Beenen, Amke C., et al.
Publicado: (2022)

Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
por: Sehnert, Bettina, et al.
Publicado: (2020)

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells
por: Shimizu, Kanako, et al.
Publicado: (2015)

Breaking Entry-and Species Barriers: LentiBOOST(®) Plus Polybrene Enhances Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5
por: Strack, Astrid, et al.
Publicado: (2022)

Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
por: Boscheinen, Jan B., et al.
Publicado: (2019)

The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells
por: Lechmann, Matthias, et al.
Publicado: (2001)

Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction
por: Knorr, Maike, et al.
Publicado: (2014)

NK cells and monocytes modulate primary HTLV-1 infection
por: Moles, Ramona, et al.
Publicado: (2022)

Cell-Intrinsic NF-κB Activation Is Critical for the Development of Natural Regulatory T Cells in Mice
por: Gückel, Eva, et al.
Publicado: (2011)

Phenotype and Function of CD209(+) Bovine Blood Dendritic Cells, Monocyte-Derived-Dendritic Cells and Monocyte-Derived Macrophages
por: Park, Kun Taek, et al.
Publicado: (2016)

Blood Eosinophilia Is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA
por: Moreira, Alvaro, et al.
Publicado: (2020)

The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
por: Simon, Bianca, et al.
Publicado: (2018)

The Modular Nature of Dendritic Cell Responses to Commensal and Pathogenic Fungi
por: Rizzetto, Lisa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0s6i2cut4og5sg0totfdvvbh1j